- Home
- NAGE vs REAL Comparison
NAGE vs REAL Comparison
Compare NAGE & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- REAL
- Stock Information
- Founded
- NAGE 1999
- REAL 2011
- Country
- NAGE United States
- REAL United States
- Employees
- NAGE N/A
- REAL N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- REAL Other Specialty Stores
- Sector
- NAGE Health Care
- REAL Consumer Discretionary
- Exchange
- NAGE Nasdaq
- REAL Nasdaq
- Market Cap
- NAGE 861.0M
- REAL 641.9M
- IPO Year
- NAGE N/A
- REAL 2019
- Fundamental
- Price
- NAGE $10.82
- REAL $5.65
- Analyst Decision
- NAGE Strong Buy
- REAL Buy
- Analyst Count
- NAGE 2
- REAL 5
- Target Price
- NAGE $12.00
- REAL $8.40
- AVG Volume (30 Days)
- NAGE 1.2M
- REAL 4.5M
- Earning Date
- NAGE 05-07-2025
- REAL 05-08-2025
- Dividend Yield
- NAGE N/A
- REAL N/A
- EPS Growth
- NAGE N/A
- REAL N/A
- EPS
- NAGE 0.18
- REAL N/A
- Revenue
- NAGE $107,925,000.00
- REAL $616,717,000.00
- Revenue This Year
- NAGE $25.46
- REAL $11.45
- Revenue Next Year
- NAGE $21.72
- REAL $10.09
- P/E Ratio
- NAGE $60.46
- REAL N/A
- Revenue Growth
- NAGE 29.77
- REAL 11.89
- 52 Week Low
- NAGE $2.31
- REAL $2.24
- 52 Week High
- NAGE $11.16
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- REAL 50.42
- Support Level
- NAGE N/A
- REAL $4.98
- Resistance Level
- NAGE N/A
- REAL $5.64
- Average True Range (ATR)
- NAGE 0.00
- REAL 0.33
- MACD
- NAGE 0.00
- REAL 0.00
- Stochastic Oscillator
- NAGE 0.00
- REAL 67.68
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.